Pieris Pharma (NASDAQ: PIRS) 11.7% HIGHER; reported Q4 EPS of ($0.07), versus ($0.21) reported last year. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

MKM Partners Reiterated Buy on Five Below (FIVE) Following Strong 4Q Results March 23, 2016 2:37 PM UBS Reiterates Buy on Red Hat (RHT) Following 4Q Report March 23, 2016 9:35 AM Drexel Hamilton Raises Price target on Red Hat (RHT) Following a Strong 4Q Showing March 23, 2016 9:05 AM Jefferies Remains Bullish on Nike (NKE) Following 3Q EPS Beat - PT to $74 March 23, 2016 8:09 AM Wedbush Cuts Price Target on Krispy Kreme Doughnuts (KKD) Following Mixed 4Q March 23, 2016 7:47 AM Sterne Agee CRT Reiterates Buy on Nike (NKE) as Low Tax Rates Boost EPS March 23, 2016 7:33 AM Needham & Company Remains Bullish Following Red Hat's (RHT) Solid 4Q Results March 23, 2016 7:22 AM Mizuho Securities Reiterates Buy on Red Hat (RHT) Following 4Q Earnings Report March 23, 2016 7:14 AM